静脉化疗联合经皮穿刺无水酒精肝转移瘤内注射治疗肺癌伴肝转移的疗效  

Efficiency of intravenous chemotherapy combined with percutaneous ethanol injection on lung cancer with liver metastasis

作　　者：张诚胜 刘先领[1] 

机构地区：[1]中南大学湘雅二医院,湖南长沙410008 [2]海南省农垦总医院,海南海口570311

出　　处：《现代肿瘤医学》2016年第18期2906-2909,共4页Journal of Modern Oncology

摘　　要：目的:观察静脉化疗联合经皮穿刺无水酒精肝转移瘤内注射(PEI)治疗肺癌伴肝转移的治疗效果。方法:收集70例肺癌伴肝转移患者,分别接受静脉化疗和静脉化疗联合PEI治疗,分析两组患者的近期治疗效果、不良反应发生情况及2年内的生存情况。结果:观察组患者的治疗有效率、无进展生存时间及总生存时间显著高于对照组患者(P<0.05);观察组患者的不良反应发生率略高于对照组,但无明显差异(P>0.05)。结论:静脉化疗联合PEI可以有效提高肺癌伴肝转移患者的近期疗效和长期生存情况,且其不良反应可耐受,适合在临床进一步推广。Objective： To explore the effect of intravenous chemotherapy combined percutaneous enthanol injection（ PEI） on lung cancer with liver metastasis. Methods： Collected 70 cases lung cancer with liver metastasis patients,they were treated with chemotherapy and chemotherpy combined PEI,analyzed the recent therapy effect,abverse reactions and 2- year survival. Results： The recent treatment efficiency and 2- year survival circumustance of observation group was better than control group（ P〈0. 05）. The incidence of adverse reaction in observatin group was slightly higher than control group,but had no statistical difference（ P〈0. 05）. Conclusion： Intravenous chemotherapy combined PEI can significantly improve patients recent curative effect and long- term survival,adverse reaction are tolerent.

关 键 词：静脉化疗 无水酒精瘤内注射 肝转移 肺癌 

分 类 号：R734.2[医药卫生—肿瘤] R735.7[医药卫生—临床医学]